The company has a very strong R&D base, which draws on both internal and external resources. Its innovative formulation technology, coupled with advanced packaging techniques aim to maximise product efficacy against the target pest, whilst minimising any potential risk to the user, non-target species, and the environment.
PelGar focuses on two sectors of the public health market: Rodenticides – PelGar works only with second-generation anticoagulants and, through a co-operative venture, is a basic manufacturer of difenacoum, bromadiolone and brodifacoum. Insecticides – based mainly on the synthetic pyrethroids and phenyl urea insect growth regulators (IGR’s).
PelGar’s experienced staff have a broad range of knowledge in the public health market including a deep practical knowledge of:
PelGar has defended all three of its rodenticide actives, difenacoum, bromadiolone and brodifacoum, through the European Biocidal Products Directive (BPD). This allows PelGar to support customers with full regulatory support for both the rodenticide actives and specific formulations. PelGar International Ltd has been an accredited ISO 9001 company since 1998. PelGar International Ltd is a wholly owned subsidiary of PelGar (Holdings) PLC.